Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacology down under in 2001.

S A Doggrell1

  • 1Department of Physiology and Pharmacology, School of Biomedical Sciences, The University of Queensland, Brisbane, Australia.

Drug News & Perspectives
|June 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Do interventions by allied health professionals discussing adherence to insulin improve this adherence?

Diabetes research and clinical practice·2014
Same author

Does intervention by an allied health professional discussing adherence to medicines improve this adherence in Type 2 diabetes?

Diabetic medicine : a journal of the British Diabetic Association·2010
Same author

The heart as a target for oestrogens.

Heart, lung & circulation·2005
Same author

Clinical evidence for drug treatments in obesity-associated hypertensive patients--a discussion paper.

Methods and findings in experimental and clinical pharmacology·2005
Same author

Responsiveness, affinity constants and beta 2-adrenoceptor reserves for isoprenaline on portal veins from normo- and pre- and hypertensive rats.

Autonomic & autacoid pharmacology·2003
Same author

Pharmacology down under in 2000.

Drug news & perspectives·2003

The Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists meeting focused on cardiovascular research and neuroprotection. Discussions explored pulmonary hypertension drugs, cardiovascular disease links, and challenges in translating neuroprotective agents from animal studies to human clinical applications.

Area of Science:

  • Pharmacology
  • Toxicology
  • Cardiovascular Research
  • Neuroscience

Background:

  • The Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT) annual meeting convenes experts in pharmacology and toxicology.
  • The 2001 ASCEPT meeting specifically addressed advancements and challenges in cardiovascular research and neurodegeneration/neuroprotection.

Purpose of the Study:

  • To summarize key research areas presented at the 2001 ASCEPT meeting.
  • To highlight ongoing investigations in cardiovascular disease and neuroprotection strategies.
  • To discuss the translational gap for neuroprotective agents in clinical settings.

Main Methods:

  • The abstract summarizes discussions and research areas presented at a scientific conference.

Related Experiment Videos

  • No specific experimental methods are detailed, but research themes are identified.

    • Main Results:

    • Cardiovascular research presented included work on pulmonary hypertension treatments, the role of superoxide dismutase in cardiovascular disease, and angiogenesis.
    • Significant discussion centered on the failure of promising neuroprotective agents in clinical trials despite success in animal models.
    • New potential agents and therapeutic targets for neuroprotection were explored.

    Conclusions:

    • The 2001 ASCEPT meeting underscored the dynamic nature of cardiovascular research and the critical challenges in neuroprotection.
    • Translating preclinical neuroprotection findings to effective clinical treatments remains a significant hurdle.
    • Continued research into novel therapeutic targets and agents is crucial for advancing neuroprotection and cardiovascular health.